Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Regulated Mammalian Expression System Technical Manual

Instructions for Use of Product(s)

Literature # TM289

The Regulated Mammalian Expression System is designed to allow tight control of gene expression in mammalian cells. The system is based on a novel on/off switch that relies on the rapid and sensitive modulation of a chimeric transactivator protein by coumerin-related compounds. Nanomolar concentrations of the antibiotic coumermycin (i.e., coumermycin A1) promote homodimerization of a chimeric transactivator resulting in activation and binding to operator sequences located upstream of a minimal promoter that drives transcription of the coding sequence of interest. The levels of protein expression can be regulated by adjusting the coumermycin concentration. The expression can be rapidly switched off by adding novobiocin, which acts as an antagonist by dissociating the dimerized transactivator protein, inhibiting expression.

Summary of Changes
The following change was made to the 10/18 revision of this document:
1. Recommended preparation of novobiocin solution was updated for clarity in Section 4.D.

Printed in USA. Revised 10/18